Generic Name and Formulations:
Hexachlorophene 3%; emulsion.
Indications for PHISOHEX:
Surgical scrub and bacteriostatic skin cleanser.
Infants: not recommended. Others: see literature.
Burns. Denuded skin. Do not use as an occlusive dressing, wet pack or lotion or on mucous membranes. Do not get into eyes. Routine prophylactic total body bathing. Generalized dermatological conditions.
Rinse thoroughly after use (esp. scrotum and perineum). If cerebral irritability occurs, discontinue use immediately. Infants and young children. Pregnancy (Cat. C). Nursing mothers: not recommended.
Dermatitis, irritability, photosensitivity, redness, mild scaling and dryness of skin. Severe toxic reactions (brain damage and death) via skin absorption in infants and young children.
Emulsion—5 oz, pt, gal
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Managing Immune-Related Adverse Events
- PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC